Dudediligence.

Bicara Therapeutics Inc

BCAXNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$17.5MSep ’24−$21.0MDec ’24−$36.8MMar ’25−$27.4MJun ’25−$36.3MSep ’25−$37.4MDec ’25−$56.2MMar ’26−$55.4MJun ’26
Fiscal years, by the month each ended
LineDec 2022Dec 2023Dec 2024Dec 2025
Operating incomenone on file−$39.9M−$82.4M−$155.6M
Net incomenone on file−$52.0M−$68.0M−$137.9M
Operating cash flownone on file−$45.6M−$74.8M−$106.8M
Free cash flownone on file−$46.2M−$74.8M−$107.1M
Cash$4.2M$230.4M$489.7M$96.7M
Shares outstandingnone on file640.4K54.4M56.6M